Bahl & Gaynor Inc Danaher Corp Transaction History

Bahl & Gaynor Inc

$19.3 Billion
Q3 2024

A detailed history of Bahl & Gaynor Inc transactions in Danaher Corp stock. As of the latest transaction made, Bahl & Gaynor Inc holds 2,704 shares of DHR stock, worth $635,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,704

Previous 2,796 3.29%

Holding current value

$635,575

Previous $698,000 7.59%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$239.25 - $280.76 $22,011 - $25,829	-92 Reduced 3.29%	2,704 $751,000
Q2 2024 Aug 07, 2024	SELL	$235.51 - $267.98 $2,826 - $3,215	-12 Reduced 0.43%	2,796 $698,000
Q1 2024 May 10, 2024	SELL	$224.58 - $256.19 $11,229 - $12,809	-50 Reduced 1.75%	2,808 $701,000
Q4 2023 Feb 02, 2024	SELL	$185.1 - $233.13 $5,553 - $6,993	-30 Reduced 1.04%	2,858 $661,000
Q3 2023 Nov 03, 2023	BUY	$233.08 - $265.59 $35,894 - $40,900	154 Added 5.63%	2,888 $716,000
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $59,397 - $67,620	-264 Reduced 8.81%	2,734 $656,000
Q1 2023 May 03, 2023	BUY	$239.75 - $277.0 $33,085 - $38,226	138 Added 4.83%	2,998 $755,000
Q4 2022 Feb 10, 2023	BUY	$241.42 - $282.29 $61,803 - $72,266	256 Added 9.83%	2,860 $759,000
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $15,070 - $91,951	-61 Reduced 2.29%	2,604 $673,000
Q2 2022 Aug 08, 2022	SELL	$237.11 - $299.66 $35,092 - $44,349	-148 Reduced 5.26%	2,665 $676,000
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $4,965 - $5,593	17 Added 0.61%	2,813 $926,000
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $141,549 - $172,863	-520 Reduced 15.68%	2,796 $851,000
Q2 2021 Aug 06, 2021	SELL	$225.08 - $271.69 $11,254 - $13,584	-50 Reduced 1.49%	3,316 $890,000
Q1 2021 May 11, 2021	BUY	$212.38 - $245.9 $21,238 - $24,590	100 Added 3.06%	3,366 $758,000
Q4 2020 Feb 02, 2021	SELL	$212.5 - $245.46 $5,312 - $6,136	-25 Reduced 0.76%	3,266 $726,000
Q3 2020 Nov 12, 2020	SELL	$177.16 - $215.33 $10,629 - $12,919	-60 Reduced 1.79%	3,291 $709,000
Q2 2020 Aug 13, 2020	SELL	$128.7 - $176.83 $1,673 - $2,298	-13 Reduced 0.39%	3,351 $593,000
Q1 2020 May 26, 2020	BUY	$121.39 - $169.05 $408,355 - $568,684	3,364 New	3,364 $466,000
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $413,818 - $576,291	-3,409 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $803,088 - $923,489	-6,017 Reduced 63.83%	3,409 $523,000
Q3 2019 Nov 14, 2019	SELL	$135.4 - $146.47 $6,770 - $7,323	-50 Reduced 0.53%	9,426 $1.36 Million
Q2 2019 Aug 12, 2019	BUY	$124.88 - $143.73 $43,208 - $49,730	346 Added 3.79%	9,476 $1.35 Million
Q3 2018 Nov 09, 2018	SELL	$98.13 - $108.9 $14,719 - $16,335	-150 Reduced 1.62%	9,130 $992,000
Q1 2018 May 11, 2018	SELL	$92.16 - $103.8 $62,208 - $70,065	-675 Reduced 6.78%	9,280 $909,000
Q4 2017 Feb 13, 2018	BUY	$85.26 - $94.62 $44,761 - $49,675	525 Added 5.57%	9,955 $924,000
Q3 2017 Nov 13, 2017	SELL	$79.29 - $88.45 $63,432 - $70,760	-800 Reduced 7.82%	9,430 $809,000
Q2 2017 Aug 11, 2017	BUY	N/A	90 Added 0.89%	10,230 $863,000
Q2 2017 Aug 10, 2017	BUY	N/A	10,140	10,140 $790,000

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Account